Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Market Research Report : Clinical trials market in india 2014 - Sample

2,215 views

Published on

For the complete report, get in touch with us at: info@netscribes.com

Published in: Business
  • Be the first to comment

Market Research Report : Clinical trials market in india 2014 - Sample

  1. 1. Clinical Trials Market – India July 2014
  2. 2. 2CLINICAL TRIALS MARKET IN INDIA 2014.PPT Executive Summary Market Drivers & Challenges Government Regulations Competition  Clinical trials market in India was valued at INR x1 bn in 2013 and is estimated to reach INR x2 bn by 2018, growing at a CAGR of y1%  India’s share in the global clinical trials market was y2% in 2013 Drivers: –Cost competitiveness –Vast patient population with diverse number of diseases –Increasing R&D expenditure by pharmaceutical companies –Sound medical infrastructure –International quality standards Challenges: –New regulations brought in several challenges –Delays in trial approval –Shortage of research professionals –Challenges of unethical trials Clinical trial can be initiated only after approval from Drugs Controller General of India (DCGI) and are governed by Schedule Y of Drugs and Cosmetics Act Registration of trials involving humans has been made mandatory starting in Jun 2009 on the Clinical Trials Registry-India (CTRI) website Major Players Company A Company B Company C Company D Company E Company F Company G Company H
  3. 3. 3CLINICAL TRIALS MARKET IN INDIA 2014.PPT •Macroeconomic Indicators •Introduction •Market Overview •Drivers & Challenges •Government Participation •Competitive Landscape Clinical Research Organizations (CROs) Clinical Research Institutes •Recent Developments •Strategic Recommendations •Appendix
  4. 4. 4 Economic Indicators (1/3) 11 12 13 14 15 b2 a2 Q1 d1 c1 b1 a1 Q4 c4 b4 a4 Q3 c3 b3 a3 Q2 d2 c2 INR tn 2013-142012-132011-122010-11 GDP at Factor Cost: Quarterly Inflation Rate: Monthly -2 -1 0 1 2 q Jul 2013 - Aug 2013 p % Nov 2013 - Dec 2013 t Oct 2013 - Nov 2013 s Sep 2013 - Oct 2013 r Aug 2013 - Sep 2013 CLINICAL TRIALS MARKET IN INDIA 2014.PPT
  5. 5. 5CLINICAL TRIALS MARKET IN INDIA 2014.PPT Globally, the clinical research market is gaining importance mainly due to the rising number of new drugs • China is the leader in the global clinical trials market followed by Turkey and Malaysia  Liberal regulatory environment supports clinical trials  The government encourages pharmaceutical and biotechnology industries to invest in new drugs and procedures for treating cancer and AIDS patients •In 2013, the global market size of clinical research market was INR x1 bn where the USA contributes y1% of the business followed by UK • The major trend in the global market is the rise in investment by the pharmaceutical and the device companies in countries with emerging economies  Multinational pharmaceuticals prefer Asian countries for clinical trials to overcome the various challenges of drug discovery and development •Globally, the major problem for conducting clinical trials is patient recruitment Global Market - Overview Share of Human Clinical Trials (2013) x3 x2 x1 Segment 3 Segment 2 Segment 1 The cost of carrying out clinical research in Russia, Argentina, China and India is half the amount required in the USA CRO Market Size and Growth (Value-wise) t s r q p INR bn X% 2018e a6 2017e a5 2016e a4 2015e a3 2014e a2 2013 a1
  6. 6. 6CLINICAL TRIALS MARKET IN INDIA 2014.PPT India is emerging as a preferred destination for clinical trials and the market is expected to show steady growth Market Overview Market Size and Growth (Value-wise) Research Institutions Global Pharma Companies Drug Discovery Clinical Trials Outsource Contract Research Organizations •Clinical trial market in India has the potential to become the hub for conducting major global multinational clinical trials •Major sponsors for clinical trials are international pharmaceuticals companies with huge R&D spending  India has a large genetic pool and has a large number of patients suffering from acute chronic disease  There are around 60,000 doctors, 45,000 hospitals and 900,000 beds in both public and private hospitals with electronic medical record facilities in most of them • Many Indian and foreign pharmaceutical companies have tied up with other specialist research companies for development of new drugs • Pharmaceutical companies are leaning towards outsourcing and concentrating on marketing without spending time for drug discovery and manufacturing • India’s competitive advantage in generic drugs makes it a potential hub for conducting clinical trials India has 16% of the world population and 20% of the global burden of diseases t s r q p INR bn X% 2018e a6 2017e a5 2016e a4 2015e a3 2014e a2 2013 a1
  7. 7. 7 Drivers & Challenges – Summary Drivers Cost competitiveness Vast patient population with diverse number of diseases Increasing R&D expenditure by pharmaceutical companies Sound medical infrastructure International quality standards Challenges New regulations have brought in several challenges Delays in trial approval Shortage of research professionals Challenges of unethical trials CLINICAL TRIALS MARKET IN INDIA 2014.PPT
  8. 8. 8 SAMPLEPorter’s Five Forces Analysis Competitive RivalryBargaining Power of Suppliers Bargaining Power of Buyers Threat of Substitutes Threat of New Entrants Impact x Impact x Impact x Impact x Impact x *Note: BEP (Break-even point) CLINICAL TRIALS MARKET IN INDIA 2014.PPT
  9. 9. 9 SAMPLEKey Ratios of Top 3 Companies – Operational Basis (FY 2013) (1/3) Competitive Benchmarking (2/5) 0 10 20 30 40 % Company C b3a3 Company B b2a2 Company A b1 a1 Operating Margin Net Margin • Company A recorded operating margin of x1%, higher than that of Company B which recorded operating margin of y2% but lower than that of Company C which recorded operating margin of z3% • Net margin for Company A , Company B and Company C are a1%, b2% and c3% respectively, wherein Company A has the highest net margin among these three companies CLINICAL TRIALS MARKET IN INDIA 2014.PPT
  10. 10. 10 SAMPLE Private: Domestic Company – Company 1 (1/5) Key People Products and Services Company Information Offices and Centres – India Name Designation Person 1 Director Person 2 Director Person 3 Director Person 4 Director Corporate Address Tel No. Fax No. Website Year of Incorporation Head Office Category Products/Services Ready Meals Instant Mixes Others Mumbai CLINICAL TRIALS MARKET IN INDIA 2014.PPT
  11. 11. 11 SAMPLE Private: Domestic Company – Company 1 (2/5) Shareholders of the Company Ownership Structure Name No. of Shares held 23.6% 57.4% 19.0% Segment Segment Segment CLINICAL TRIALS MARKET IN INDIA 2014.PPT
  12. 12. 12 SAMPLEFinancial Snapshot Key Ratios Particulars y-o-y change (2013-12) 2013 2012 2011 2010 Profitability Ratios Operating Margin Net Margin Profit Before Tax Margin Return on Equity Return on Capital Employed Return on Working Capital Return on Assets Return on Fixed Assets Cost Ratios Operating costs (% of Sales) Administration costs (% of Sales) Interest costs (% of Sales) Liquidity Ratios Current Ratio Cash Ratio Leverage Ratios Debt to Equity Ratio Debt to Capital Ratio Interest Coverage Ratio Efficiency Ratios Fixed Asset Turnover Asset Turnover Current Asset Turnover Working Capital Turnover Capital Employed Turnover Private: Domestic Company – Company 1 (3/5) Improved Decline Financial Summary • The company earned a net profit of INR x1 mn in FY 2011, as compared to net profit of INR x2 mn in FY 2010 • The company reported total income of INR x3 mn in FY 2011, registering an increase of x4% over FY 2010 • The company earned an operating margin of x5% in FY 2011, an increase of x6 percentage points over FY 2010 • The company reported debt to equity ratio of x7 in FY 2011, a decrease of x8% over FY 2010 Net Profit/LossTotal Income a t s r q f p b c d e b4 a4 20112008 a1 b1 2010 a3 b3 2009 a2 b2 CLINICAL TRIALS MARKET IN INDIA 2014.PPT
  13. 13. 13 SAMPLE 13 Description News Overview • Company 2 has hospital network in Country A, Country B and Country C and is primarily headquartered in Country D • Presently located in 10 cities in India having hospitals in Region 1, Region 2 and Region 3 Facilities • Has core specialties in heart care, brain and spine, bone and joint and minimal access surgery • Provides advanced medical diagnostics and treatment with personal care Recognitions • Obtained NABH accreditation within one and a half years of beginning operation in India • Hospital A, Region 1, Hospital B, Region 2 has been NABH accredited Business Highlights Private: Domestic Company – Company 1 (3/5) CLINICAL TRIALS MARKET IN INDIA 2014.PPT
  14. 14. 14 SAMPLE TO WS Private: Domestic Company – Company 1– SWOT Analysis (5/5) CLINICAL TRIALS MARKET IN INDIA 2014.PPT
  15. 15. 15 Thank you for the attention About Netscribes, Inc. Netscribes, Inc. is a knowledge-consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment & business research, business & corporate intelligence, content-management services, and knowledge-software services. At its core lies a true value proposition that draws upon a vast knowledge base. Netscribes, Inc. is a one-stop shop designed to fulfil clients’ profitability and growth objectives. Clinical Trials Market in India 2014 – India report is part of Netscribes’ Healthcare Series. For any queries or customized research requirements, contact us at: Disclaimer: This report is published for general information only. Although high standards have been used in the preparation, “Netscribes” is not responsible for any loss or damage arising from use of this document. This document is the sole property of Netscribes and prior permission is required for guidelines on reproduction. Phone: +91 22 4098 7600 E-Mail: info@netscribes.com CLINICAL TRIALS MARKET IN INDIA 2014.PPT

×